A Phase 2 Randomised, Double-blind, Placebo-controlled Multiple Ascending Dose Study Evaluate the Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis

NCT02029599 Phase 2 COMPLETED

The aim of this study is to evaluate the efficacy and safety of Fang yi qing Feng shi granules in subjects with Rheumatoid Arthritis.

Details

Lead sponsor	Maoxiang Group Jilin Pharmaceutical Co., Ltd.
Phase	Phase 2
Status	COMPLETED
Enrolment	240
Start date	2014-03

Conditions

• Rheumatoid Arthritis

Interventions

• Fang yi qing feng shi granule
• placebo
• Methotrexate
• Acetaminophen tablets

Primary outcomes

• The percentage of Therapeutic effect with American College of Rheumatology standards (ACR) — Taken at day 1 (baseline) and Change from Baseline in 4th,8th,12th week

Countries

China